OVA CircRNA-LNP is a state-of-the-art circular RNA (CircRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates circRNA encoding the OVA (Ovalbumin) model antigen, serving as an excellent tool for studying immune responses and evaluating vaccine delivery platforms. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. We offer flexibility in lipid composition, including DLin-MC3-DMA, LP-01, ALC-0315, SM102, and targeted lipids for specific tissues (lung, liver, spleen, muscle), allowing for tailored delivery strategies. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of OVA CircRNA-LNP include monitoring circRNA-based antigen expression and assessing immune response induction. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear AllInquiry
For Research Use Only. Not for Diagnostic or Treatment Applications.
Payload Type
CircRNA
Payload
OVA CircRNA
Modification
Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
